Inactivation of the serpin α2-antiplasmin by stromelysin-1

Biochimica et Biophysica Acta- Protein Structure and Molecular Enzymology

Volumn 1547, Issue 2, 2001, Pages 206-213

  Lijnen, H Roger ^a   Van Hoef, Berthe ^a   Collen, Désiré ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

Matrix metalloproteinase; Serpin; Stromelysin 1; 2 Antiplasmin

Indexed keywords

ALPHA 2 ANTIPLASMIN; FIBRIN; PEPTIDE; PLASMIN INHIBITOR; PLASMINOGEN; SERINE PROTEINASE INHIBITOR; STROMELYSIN;

ARTICLE; BINDING SITE; CROSSED IMMUNOELECTROPHORESIS; ENZYME ACTIVITY; ENZYME INACTIVATION; ENZYME SUBSTRATE; GEL; HALF LIFE TIME; HYDROLYSIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN INTERACTION; REGULATORY MECHANISM;

ANTIPLASMIN; DENSITOMETRY; ELECTROPHORESIS, POLYACRYLAMIDE GEL; IMMUNOELECTROPHORESIS, TWO-DIMENSIONAL; MATRIX METALLOPROTEINASE 3; PEPTIDE FRAGMENTS; PLASMIN; TIME FACTORS;

EID: 0035844697     PISSN: 01674838     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-4838(01)00186-8     Document Type: Article

References (37)

1. Fibrinolysis
2. 2-antiplasmin
3. 2-antiplasmin, a serine protease inhibitor (serpin)
4. Identification and some properties of a new fast-reacting plasmin inhibitor in human plasma
5. 2-plasmin inhibitor from human plasma. A novel proteinase inhibitor which inhibits activator-induced clot lysis
6. The primary inhibitor of plasmin in human plasma
7. 2-plasmin inhibitor in human plasma
8. 2-plasmin inhibitor
9. 2-antiplasmin and plasmin
10. On the kinetics of the reaction between human antiplasmin and plasmin
11. Congenital and acquired deficiencies of components of the fibrinolytic system and their relation to bleeding or thrombosis
12. 2-antiplasmin molecule associated with an autosomal recessive hemorrhagic disorder
13. 2-antiplasmin Enschede: Alanine insertion and abolition of plasmin inhibitory activity
14. Matrix metalloproteinase system deficiencies and matrix degradation
15. Human fibroblast stromelysin catalytic domain: Expression, purification, and characterization of a C-terminally truncated form
16. Matrix metalloproteinases and their inhibitors
17. Degradation of cross-linked fibrin by matrix metalloproteinase 3 (stromelysin-1): Hydrolysis of the gamma Gly404-Ala405 peptide bond
18. Generation of an angiostatin-like fragment from plasminogen by stromelysin-1 (MMP-3)
19. Proteolytic cleavage of urokinase-type plasminogen activator by stromelysin-1 (MMP-3)
20. Inactivation of plasminogen activator inhibitor-1 by specific proteolysis with stromelysin-1 (MMP-3)
21. Kinetics and physiologic relevance of the inactivation of alpha 1-proteinase inhibitor, alpha 1-antichymotrypsin, and antithrombin III by matrix metalloproteinases-1 (tissue collagenase),-2 (72-kDa gelatinase/type IV collagenase), and-3 (stromelysin)
22. Proteolytic inactivation of human alpha 1 antitrypsin by human stromelysin
23. 2-antiplasmin
24. 2-antiplasmin and of mutants obtained by site-directed mutagenesis of the reactive site
25. Protein and cell membrane iodinations with a sparingly soluble chloroamide,1,3,4,6-tetrachloro-3a,6a-diphenylglycoluril
26. 2-antiplasmin) in plasma from patients with tendency to thrombosis and increased fibrinolysis
27. 2-plasmin inhibitor to plasminogen
28. Cellular regulation of fibrinolysis
29. 2-antiplasmin. Homology with other plasma protease inhibitors
30. 2-antiplasmin in plasma which does not interact with the lysine-binding sites in plasminogen
31. 2-plasmin inhibitor
32. 2-Antiplasmin gene deficiency in mice is associated with enhanced fibrinolytic potential without overt bleeding
33. Development and disease in proteinase-deficient mice: Role of the plasminogen, matrix metalloproteinase and coagulation system
34. Interstitial collagenase (matrix metalloproteinase-1) expresses serpinase activity
35. Hydrolytic inactivation of a breast carcinoma cell-derived serpin by human stromelysin-3
36. Inactivation of human plasma alpha 1-proteinase inhibitor by human PMN leucocyte collagenase
37. Proteolytic inactivation of alpha 1-proteinase inhibitor and alpha 1-antichymotrypsin by oxidatively activated human neutrophil metalloproteinases